Wegovy is specifically approved for weight management in adults with obesity or those who are overweight with weight-related health conditions
Once you start thinking in terms of temperature rather than location, managing your medication becomes much simpler and far less stressful
While one core molecule patent expired in March 2026, Novo Nordisk retains formulation and delivery device patents through the early 2030s
Semaglutide in injection forms follows a weekly dosing schedule, which can make it more challenging to remember to take your dose than with a daily medication
However, many insurance providers, including United Healthcare, Cigna, and Blue Cross Blue Shield, may cover semaglutide as a necessary treatment for weight management, often requiring prior authorization